Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Lutathera to treat gastroenteropancreatic neuroendocrine tumors

Jan. 29, 2018

Adocia reports topline results from phase Ib study of BioChaperone Combo

Jan. 29, 2018

First patient dosed in phase II study of MCLA-128 in breast cancer

Jan. 29, 2018

CHMP supports approval of Shingrix for prevention of shingles in adults aged 50 and over

Jan. 29, 2018

CHMP grants positive opinion for labeling update to Relvar Ellipta in patients with asthma

Jan. 29, 2018

SUSD2 shown as predictor of recurrence after gastric cancer resection

Jan. 26, 2018

Atea Pharmaceuticals patents new antiviral nucleotide derivatives

Jan. 26, 2018

Novel HIV maturation inhibitors described by ViiV Healthcare

Jan. 26, 2018

The University of California, Oakland divulges novel anticancer compounds

Jan. 26, 2018

New TGF-beta receptor type-1 inhibitors patented by Hanmi

Jan. 26, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...